FIFY THOMAS: Open Payments
NPI 1669054953 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 40 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $251 · 2025 $1,439
Food & beverage: $1,439
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $391 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $263 |
| Novartis Pharmaceuticals Corporation | 9 | $256 |
| AstraZeneca Pharmaceuticals LP | 10 | $249 |
| BridgeBio Pharma, Inc. | 5 | $129 |
| Amgen Inc. | 2 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $31 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
Products named: Rapiblyk, Kerendia, LEQVIO, Attruby, WAINUA, FARXIGA, REPATHA, FUROSCIX.
Industry payments across IL — which companies pay providers there.
